Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition.

Jia D, Augert A, Kim DW, Eastwood E, Wu N, Ibrahim AH, Kim KB, Dunn CT, Pillai SPS, Gazdar AF, Bolouri H, Park KS, MacPherson D.

Cancer Discov. 2018 Nov;8(11):1422-1437. doi: 10.1158/2159-8290.CD-18-0385. Epub 2018 Sep 4.

PMID:
30181244
2.

Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates.

Lomonaco S, Crawford MA, Lascols C, Timme RE, Anderson K, Hodge DR, Fisher DJ, Pillai SP, Morse SA, Khan E, Hughes MA, Allard MW, Sharma SK.

PLoS One. 2018 Jun 8;13(6):e0198526. doi: 10.1371/journal.pone.0198526. eCollection 2018.

3.

Phylogenetic inference of Coxiella burnetii by 16S rRNA gene sequencing.

McLaughlin HP, Cherney B, Hakovirta JR, Priestley RA, Conley A, Carter A, Hodge D, Pillai SP, Weigel LM, Kersh GJ, Sue D.

PLoS One. 2017 Dec 29;12(12):e0189910. doi: 10.1371/journal.pone.0189910. eCollection 2017.

4.

Closed Genome Sequence of Chryseobacterium piperi Strain CTMT/ATCC BAA-1782, a Gram-Negative Bacterium with Clostridial Neurotoxin-Like Coding Sequences.

Wentz TG, Muruvanda T, Lomonaco S, Thirunavukkarasu N, Hoffmann M, Allard MW, Hodge DR, Pillai SP, Hammack TS, Brown EW, Sharma SK.

Genome Announc. 2017 Nov 30;5(48). pii: e01296-17. doi: 10.1128/genomeA.01296-17.

5.

Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.

Graves SS, Parker MH, Stone D, Sale GE, Pillai SPS, Johnson MM, Storb R.

Biol Blood Marrow Transplant. 2018 Jan;24(1):50-54. doi: 10.1016/j.bbmt.2017.09.010. Epub 2017 Sep 25.

PMID:
28958896
6.

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.

Craddock CF, Houlton AE, Quek LS, Ferguson P, Gbandi E, Roberts C, Metzner M, Garcia-Martin N, Kennedy A, Hamblin A, Raghavan M, Nagra S, Dudley L, Wheatley K, McMullin MF, Pillai SP, Kelly RJ, Siddique S, Dennis M, Cavenagh JD, Vyas P.

Clin Cancer Res. 2017 Nov 1;23(21):6430-6440. doi: 10.1158/1078-0432.CCR-17-1423. Epub 2017 Aug 1.

7.

Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.

Smith TT, Moffett HF, Stephan SB, Opel CF, Dumigan AG, Jiang X, Pillarisetty VG, Pillai SPS, Wittrup KD, Stephan MT.

J Clin Invest. 2017 Jun 1;127(6):2176-2191. doi: 10.1172/JCI87624. Epub 2017 Apr 24.

8.

In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.

Smith TT, Stephan SB, Moffett HF, McKnight LE, Ji W, Reiman D, Bonagofski E, Wohlfahrt ME, Pillai SPS, Stephan MT.

Nat Nanotechnol. 2017 Aug;12(8):813-820. doi: 10.1038/nnano.2017.57. Epub 2017 Apr 17.

9.

A New Preclinical Paradigm for Testing Anti-Aging Therapeutics.

Ladiges W, Snyder JM, Wilkinson E, Imai DM, Snider T, Ge X, Ciol M, Pettan-Brewer C, Pillai SPS, Morton J, Quarles E, Rabinovitch P, Niedernhofer L, Liggitt D.

J Gerontol A Biol Sci Med Sci. 2017 Jun 1;72(6):760-762. doi: 10.1093/gerona/glx019.

10.

Genome Sequences of Multidrug-Resistant, Colistin-Susceptible and -Resistant Klebsiella pneumoniae Clinical Isolates from Pakistan.

Crawford MA, Timme R, Lomonaco S, Lascols C, Fisher DJ, Sharma SK, Strain E, Allard MW, Brown EW, McFarland MA, Croley T, Hammack TS, Weigel LM, Anderson K, Hodge DR, Pillai SP, Morse SA, Khan E, Hughes MA.

Genome Announc. 2016 Dec 15;4(6). pii: e01419-16. doi: 10.1128/genomeA.01419-16.

11.

Complete Genome Sequences for Three Chromosomes of the Burkholderia stabilis Type Strain (ATCC BAA-67).

Bugrysheva JV, Cherney B, Sue D, Conley AB, Rowe LA, Knipe KM, Frace MA, Loparev VN, Avila JR, Anderson K, Hodge DR, Pillai SP, Weigel LM.

Genome Announc. 2016 Nov 17;4(6). pii: e01294-16. doi: 10.1128/genomeA.01294-16.

12.

Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples.

Ramage JG, Prentice KW, DePalma L, Venkateswaran KS, Chivukula S, Chapman C, Bell M, Datta S, Singh A, Hoffmaster A, Sarwar J, Parameswaran N, Joshi M, Thirunavkkarasu N, Krishnan V, Morse S, Avila JR, Sharma S, Estacio PL, Stanker L, Hodge DR, Pillai SP.

Health Secur. 2016 Sep-Oct;14(5):351-65. doi: 10.1089/hs.2016.0041.

13.

Identification and Analysis of Informative Single Nucleotide Polymorphisms in 16S rRNA Gene Sequences of the Bacillus cereus Group.

Hakovirta JR, Prezioso S, Hodge D, Pillai SP, Weigel LM.

J Clin Microbiol. 2016 Nov;54(11):2749-2756. Epub 2016 Aug 31.

14.

Comprehensive laboratory evaluation of a specific lateral flow assay for the presumptive identification of abrin in suspicious white powders and environmental samples.

Ramage JG, Prentice KW, Morse SA, Carter AJ, Datta S, Drumgoole R, Gargis SR, Griffin-Thomas L, Hastings R, Masri HP, Reed MS, Sharma SK, Singh AK, Swaney E, Swanson T, Gauthier C, Toney D, Pohl J, Shakamuri P, Stuchlik O, Elder IA, Estacio PL, Garber EA, Hojvat S, Kellogg RB, Kovacs G, Stanker L, Weigel L, Hodge DR, Pillai SP.

Biosecur Bioterror. 2014 Jan-Feb;12(1):49-62. doi: 10.1089/bsp.2013.0080.

PMID:
24552362
15.

Intrauterine fetal death with subsequent quill exfoliation and dissemination in a North American porcupine (Erethizon dorsatum).

Cushing AC, Noonan B, Gutman MR, Pillai SP.

J Zoo Wildl Med. 2013 Dec;44(4):1102-6.

PMID:
24450079
16.

Comprehensive laboratory evaluation of a highly specific lateral flow assay for the presumptive identification of ricin in suspicious white powders and environmental samples.

Hodge DR, Prentice KW, Ramage JG, Prezioso S, Gauthier C, Swanson T, Hastings R, Basavanna U, Datta S, Sharma SK, Garber EA, Staab A, Pettit D, Drumgoole R, Swaney E, Estacio PL, Elder IA, Kovacs G, Morse BS, Kellogg RB, Stanker L, Morse SA, Pillai SP.

Biosecur Bioterror. 2013 Dec;11(4):237-50. doi: 10.1089/bsp.2013.0053. Epub 2013 Dec 9.

PMID:
24320219
17.

Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

Martin CK, Dirksen WP, Carlton MM, Lanigan LG, Pillai SP, Werbeck JL, Simmons JK, Hildreth BE 3rd, London CA, Toribio RE, Rosol TJ.

Vet Comp Oncol. 2015 Sep;13(3):203-17. doi: 10.1111/vco.12037. Epub 2013 May 8.

18.

Detection of influenza viral gene in European starlings and experimental infection.

Qin Z, Clements T, Wang L, Khatri M, Pillai SP, Zhang Y, Lejeune JT, Lee CW.

Influenza Other Respir Viruses. 2011 Jul;5(4):268-75. doi: 10.1111/j.1750-2659.2010.00190.x. Epub 2010 Dec 13.

19.

Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.

Wolfe TD, Pillai SP, Hildreth BE 3rd, Lanigan LG, Martin CK, Werbeck JL, Rosol TJ.

Clin Exp Metastasis. 2011 Apr;28(4):377-89. doi: 10.1007/s10585-011-9377-9. Epub 2011 Mar 4.

20.

Detection of influenza A viruses in eggs laid by infected turkeys.

Pillai SP, Saif YM, Lee CW.

Avian Dis. 2010 Jun;54(2):830-3.

PMID:
20608526
21.

Pathobiological characterization of low-pathogenicity H5 avian influenza viruses of diverse origins in chickens, ducks and turkeys.

Pillai SP, Pantin-Jackwood M, Suarez DL, Saif YM, Lee CW.

Arch Virol. 2010 Sep;155(9):1439-51. doi: 10.1007/s00705-010-0727-8. Epub 2010 Jun 25.

PMID:
20577770
22.

The high susceptibility of turkeys to influenza viruses of different origins implies their importance as potential intermediate hosts.

Pillai SP, Pantin-Jackwood M, Yassine HM, Saif YM, Lee CW.

Avian Dis. 2010 Mar;54(1 Suppl):522-6. Review.

PMID:
20521688
23.

A rapid antimicrobial susceptibility test for Bacillus anthracis.

Weigel LM, Sue D, Michel PA, Kitchel B, Pillai SP.

Antimicrob Agents Chemother. 2010 Jul;54(7):2793-800. doi: 10.1128/AAC.00247-10. Epub 2010 May 3.

25.

Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys.

Pillai SP, Pantin-Jackwood M, Jadhao SJ, Suarez DL, Wang L, Yassine HM, Saif YM, Lee CW.

Vaccine. 2009 Feb 5;27(6):819-24. doi: 10.1016/j.vaccine.2008.11.076. Epub 2008 Dec 9.

PMID:
19071183
26.

Pathogenicity and transmission studies of H5N2 parrot avian influenza virus of Mexican lineage in different poultry species.

Pillai SP, Suarez DL, Pantin-Jackwood M, Lee CW.

Vet Microbiol. 2008 May 25;129(1-2):48-57. Epub 2007 Nov 12.

PMID:
18077111
27.

Characterization of low-pathogenicity H5N1 avian influenza viruses from North America.

Spackman E, Swayne DE, Suarez DL, Senne DA, Pedersen JC, Killian ML, Pasick J, Handel K, Pillai SP, Lee CW, Stallknecht D, Slemons R, Ip HS, Deliberto T.

J Virol. 2007 Nov;81(21):11612-9. Epub 2007 Aug 29.

28.

Quantitative evaluation of bacteria released by bathers in a marine water.

Elmir SM, Wright ME, Abdelzaher A, Solo-Gabriele HM, Fleming LE, Miller G, Rybolowik M, Peter Shih MT, Pillai SP, Cooper JA, Quaye EA.

Water Res. 2007 Jan;41(1):3-10. Epub 2006 Nov 17.

29.

Antimutagenic/antioxidant activity of green tea components and related compounds.

Pillai SP, Mitscher LA, Menon SR, Pillai CA, Shankel DM.

J Environ Pathol Toxicol Oncol. 1999;18(3):147-58.

PMID:
15281227
30.

Reagentless detection and classification of individual bioaerosol particles in seconds.

Fergenson DP, Pitesky ME, Tobias HJ, Steele PT, Czerwieniec GA, Russell SC, Lebrilla CB, Horn JM, Coffee KR, Srivastava A, Pillai SP, Shih MT, Hall HL, Ramponi AJ, Chang JT, Langlois RG, Estacio PL, Hadley RT, Frank M, Gard EE.

Anal Chem. 2004 Jan 15;76(2):373-8.

PMID:
14719885
31.

Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.

Polyak CS, Macy JT, Irizarry-De La Cruz M, Lai JE, McAuliffe JF, Popovic T, Pillai SP, Mintz ED; Emergency Operations Center International Team.

Emerg Infect Dis. 2002 Oct;8(10):1056-9.

32.

First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001.

Traeger MS, Wiersma ST, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan PL, Pillai SP, Popovic T, Quinn CP, Meyer RF, Zaki SR, Kumar S, Bruce SM, Sejvar JJ, Dull PM, Tierney BC, Jones JD, Perkins BA; Florida Investigation Team.

Emerg Infect Dis. 2002 Oct;8(10):1029-34.

33.

The ability of certain antimutagenic agents to prevent development of antibiotic resistance.

Pillai SP, Pillai CA, Shankel DM, Mitscher LA.

Mutat Res. 2001 Sep 20;496(1-2):61-73.

PMID:
11551481
34.

Role of antimutagens/anticarcinogens in cancer prevention.

Shankel DM, Pillai SP, Telikepalli H, Menon SR, Pillai CA, Mitscher LA.

Biofactors. 2000;12(1-4):113-21.

PMID:
11216471
35.

Multiple drug resistance.

Mitscher LA, Pillai SP, Gentry EJ, Shankel DM.

Med Res Rev. 1999 Nov;19(6):477-96. Review.

PMID:
10557366
36.

Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutations.

Pillai SP, Menon SR, Mitscher LA, Pillai CA, Shankel DM.

J Nat Prod. 1999 Oct;62(10):1358-62.

PMID:
10543892
37.

Structure-antimutagenic activity relationship study of plicatin B.

Menon SR, Patel VK, Mitscher LA, Shih P, Pillai SP, Shankel DM.

J Nat Prod. 1999 Jan;62(1):102-6.

PMID:
9917292
38.

Effects of antimutagens on development of drug/antibiotic resistance in microorganisms.

Pillai SP, Shankel DM.

Mutat Res. 1998 Jun 18;402(1-2):139-50.

PMID:
9675262
39.

Polyamines and their potential to be antimutagens.

Pillai SP, Shankel DM.

Mutat Res. 1997 Jul 3;377(2):217-24.

PMID:
9247617
40.

Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents.

Mitscher LA, Jung M, Shankel D, Dou JH, Steele L, Pillai SP.

Med Res Rev. 1997 Jul;17(4):327-65. Review. No abstract available.

PMID:
9211396

Supplemental Content

Loading ...
Support Center